Echo Therapeutics, Inc. Deferred Revenue
Echo Therapeutics, Inc. had Deferred Revenue of $76.43 thousand as of 2014-09-30, per its 10-Q filed 2015-04-20.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2015-04-20
- 2014-09-30: Deferred Revenue, Current $76.43K.
- 2014-06-30: Deferred Revenue, Current $76.43K.
- 2014-03-31: Deferred Revenue, Current $76.43K.
- 2013-12-31: Deferred Revenue, Current $76.43K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2014-09-30 | $76.43K 10-Q · filed 2015-04-20 |
| 2014-06-30 | $76.43K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $76.43K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $76.43K 10-Q · filed 2015-04-20 |
| 2013-09-30 | $90.23K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $90.23K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $67.67K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $90.23K 10-K · filed 2014-03-28 |
| 2012-09-30 | $92.79K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $123.72K 10-Q · filed 2012-08-09 |
| 2012-03-31 | $123.71K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $123.71K 10-K · filed 2013-03-18 |
| 2011-09-30 | $196.29K 10-Q · filed 2011-11-08 |
| 2011-06-30 | $244.72K 10-Q · filed 2011-08-12 |
| 2010-12-31 | $405.45K 10-K · filed 2012-03-15 |